Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio Inc. joined the parade of China biopharmas...
GenePharma, a young and growing private company in...
3SBio, Inc. (NSDQ: SSRX) has signed a...
WuXi PhamaTech released positive Q1 results though...
In seventeen months, 3SBio has gone from a well-received...
ChinaBio® Today looked at the newest draft of the...
3SBio Inc. reported that Q2 revenue increased 38% to 60...
Perhaps this is the adolescent phase of China biopharma...
3SBio has filed for SFDA approval of a high-dose, 36,000...
Phynova will adopt a China-centric business plan; Crown...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
